Treatment of Co-Occurring Depression and Substance Dependence: Using Meta-Analysis to Guide Clinical Recommendations

Columbia University College of Physicians and Surgeons, and N.Y. State Psychiatric Institute, New York.
Psychiatric Annals (Impact Factor: 0.71). 12/2008; 38(11):nihpa128505. DOI: 10.3928/00485713-20081101-05
Source: PubMed

Full-text preview

Available from:
  • Source
    • "Although psychiatric comorbidity occurs in females and males, it is more frequent in females [12]. Women are twice as Nunes and Levin, 2008 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Guidelines assist practitioners in the management of opioid dependence, however, important day-to-day issues in the field must be addressed, such as "Which medication to use, how to start, how to dose, when to stop, how to manage complications and comorbidities?". The workshop aimed to define the approach to managing the gap between guidelines for opioid dependence management and the real life clinical situations. 6 expert speakers in the field of opioid dependence management presented detailed guidelines examination, the evidence for the guidelines, and expert clinical experience highlighting the practical needs for prescribers in opioid dependence management for individualised patient care and comorbidities. Results: Sufficient evidence supports the treatment of opioid dependence, but evidence gaps remain which are likely to be important in guiding specific decisions about individual patient care. Clinical experience is vital to bridge the gaps between Guidelines advice, effective individual patient tailored care in the treatment of opioid dependence. Conclusions: It is important to tailor care to individual patient needs under the consideration of evidence based facts. Initial recommendations for treatment directed by a system based on tolerance to opioids, level of existing psychopathology, and abuse of other substances could bridge the gap between Guidelines and the real life clinical setting.
    Full-text · Article · Dec 2014 · Heroin Addiction and Related Clinical Problems
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objetivo. La infección por el virus de la hepatitis C (VHC) es un hecho frecuente en los pacientes con infección por el virus de la inmunodeficiencia humana (VIH), sobre todo en aquellos con historia de drogadicción parenteral. El manejo de pacientes con abuso de alcohol y coinfección por VHC y VIH es complejo aunque imprescindible para reducir la elevada morbimortalidad. Material y métodos. Se expone el caso de un paciente de 44 años, con abuso de alcohol e infección por VHC y VIH. Se describe la historia clínica desde el punto de vista del abuso de sustancias y la evolución de ambas infecciones, así como las opciones terapéuticas para el alcoholismo y la hepatitis crónica C en los pacientes con VIH/sida. Resultados. Se inicia tratamiento para el abuso de alcohol y se optimiza el del VIH/sida para mejorar la situación inmunológica y virológica; se revisa además la idoneidad del paciente para recibir tratamiento antiviral para la hepatitis crónica C con interferón y ribavirina. Conclusión. El abordaje del abuso de alcohol y otras sustancias es esencial para un control clínico de la hepatitis crónica y el VIH.
    Full-text · Article · Jul 2009 · Trastornos Adictivos
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: ISSUES AND APPROACH: The high rates of co-occurring depression and substance use, and the negative impact of this on illness course and outcomes have been well established. Despite this, few clinical trials have examined the efficacy of cognitive behaviour therapy (CBT). This paper systematically reviews these clinical trials, with an aim of providing recommendations for how future research can develop a more robust evidence base for the treatment of these common comorbidities. Leading electronic databases, including PubMed (ISI) and PsychINFO (CSA), were searched for peer-reviewed journal articles using CBT for the treatment of co-occurring depression and substance use. Of the 55 articles identified, 12 met inclusion criteria and were included in the review. KEY FINDINGS: There is only a limited evidence for the effectiveness of CBT either alone or in combination with antidepressant medication for the treatment of co-occurring depression and substance use. While there is support for the efficacy of CBT over no treatment control conditions, there is little evidence that CBT is more efficacious than other psychotherapies. There is, however, consistent evidence of improvements in both depression and substance use outcomes, regardless of the type of treatment provided and there is growing evidence that that the effects of CBT are durable and increase over time during follow up. CONCLUSIONS: Rather than declaring the 'dodo bird verdict' that CBT and all other psychotherapies are equally efficacious, it would be more beneficial to develop more potent forms of CBT by identifying variables that mediate treatment outcomes.
    Full-text · Article · Sep 2010 · Drug and Alcohol Review
Show more